Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > FOXO4-DRI for Sale > High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - large image1
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image1
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image2
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image3
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image4
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image5
High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research buy - image6

High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research

TDS 29 Inquiries

Unit Price:

$234-258/UNIT EXW

Get Latest Price
CAS No.:

2460055-10-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shenzhen

Brand:

XiWu

Packaging:

10mg*10Vials

Price valid (until):

2027-09-30

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Description

  • Seller Information

  • History Price

  • Inquiry History

  • Description


       Product Detail   


    Whatsapp:+85244697127

    If you are interested, please feel free to contact me at any time.

    Product Introduction

    FOXO4‑DRI, also known as FOXO4 D‑Retro‑Inverso peptide, is a synthetic cell‑permeable research peptide. It belongs to D‑retro‑inverso modified peptide series. This compound is widely used for pre‑clinical laboratory studies focusing on protein‑protein interaction and cellular senescence related biological pathways. Our product is supplied as high‑purity lyophilized off‑white powder, strictly for laboratory research applications only. Each batch is verified by HPLC and MS test, complete COA documents are available upon request.

    Mechanism of Action

    FOXO4‑DRI acts as a peptide antagonist targeting FOXO4‑p53 protein binding interface. It competitively interferes with the molecular interaction between FOXO4 transcription factor and p53 protein inside target cells. This molecular interference triggers intracellular biochemical pathway rearrangement in specific cell populations. It mediates biological responses in senescent cell models while generating limited influence on normal proliferating cells in experimental settings. Researchers apply this compound to explore the downstream biological cascade triggered by disturbed FOXO4‑p53 binding.

    Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 1 Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 2 Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 3 Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 4 Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 5 Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 6

    Basic Chemical Information

    • Product Name: FOXO4‑DRI
    • CAS No.: 2460055‑10‑9
    • Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
    • Molecular Weight: 5358.06
    • Appearance: White to off‑white lyophilized powder
    • Purity: ≥98%


    Shop High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research-Detailed Image 7

    Storage Conditions

    Store sealed lyophilized powder at ‑20℃ under dry and dark environment. Avoid repeated freezing‑thawing cycles. For long‑term preservation,‑80℃ sealed storage is recommended. After reconstitution, prepare aliquot portions and store at low temperature. Keep away from moisture and contaminants to retain molecular stability.

    Approved Indications

    Strictly for laboratory scientific research use only. Not intended for human, animal diagnostic or therapeutic purposes. All experimental operations shall follow local laboratory safety specifications.

    Core Advantages

    1. D‑retro‑inverso modified peptide structure, showing improved protease‑resistant property under experimental conditions
    2. High‑purity lyophilized powder, batch‑to‑batch consistency supported by HPLC & MS testing
    3. Well‑documented reference literature available for cellular senescence pathway research
    4. Complete supporting documents including COA can be provided for laboratory project review
    5. Flexible packaging specifications to satisfy different lab‑scale experimental requirements

    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 6 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 7



    Items Specifications
    Product Name
    FOX04-DRI Peptide Lyophilized Powder
    Purity ≥99%
    Packing Way Foam + Carton


    Packaging & Logistics

    Standard packing: 10mg vials; customized specifications are acceptable.

    Sealed vacuum vial packaging to prevent moisture ingress. Cold chain transportation is optional to maintain stability. Discreet outer packaging. All goods are supplied as research raw materials.

    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 8 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 9


    Company Profile


    We are a high-tech enterprise oriented towards research and development, specializing in the fields of pharmaceutical raw materials, intermediates, peptide components, cosmetic raw materials, and nutritional supplement raw materials. We offer standardized large-scale production services and conduct global wholesale business. Our multiple peptide raw materials possess core physiological effects such as weight loss, muscle building, blood sugar reduction, and anti-aging, are widely applicable to the research and production demands in the pharmaceutical, beauty, and health care sectors.


    We adopt strict batch production standards and have sufficient production capacity and stable supply capabilities. All products have been professionally tested by third-party institutions and come with complete test reports and qualification certificates, ensuring stable batch quality and complete traceability. For large-scale orders, we offer competitive wholesale prices. We uphold the core values of integrity, pragmatism, innovation and development, and continuously enhance our technical strength and product quality.


    We offer comprehensive high-quality fine raw materials for the pharmaceutical, cosmetic and nutritional product industries. At the same time, we not only support standard batch purchases but also can meet the needs of pilot projects and large-scale industrial production.


    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 10 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 11

    ECHEMI Editorial Reference
    FOXO4-DRI (Retro-Inverso) is a synthetic, slightly modified version of the standard FOXO4 protein. The modification prolongs half-life of the protein and allows it to interfere with normal FOXO4 function. FOXO4-DRI has been shown in research to prevent normal FOXO4 binding to p53, thereby allowing for elimination of senescent cells, improved organ function, and younger tissue “biological age.” FOXO4-DRI impacts insulin signaling, cell cycle regulation, and oxidative stress signaling pathways. FOXO4-DRI is a cell penetrating peptide shown to selectively induce apoptosis of senescent cells thereby reversing effects of aging in animal studies.
    Research & Reference Note

    High Purity FOXO4-DRI Synthetic Peptide CAS 2460055-10-9 for Cell Biology and Senescence Research is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates

    Basic Info
    Product Name:

    FOXO4-DRI

    Other Name:

    FOXO4-DRI;FOXO4 /FOXO4-DRI;FOX04-DRI (D-Retro-Inverso);Fox4-dri

    CAS No.:

    2460055-10-9

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 307, No. 3, Building 7, Area 4, Pingchou, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    FOXO4-DRI

    1 G Dec 3, 2023
    Germany

    foxo4-dri

    1 G Aug 23, 2026
    United States

    Fox04-dri

    1 G May 20, 2026
    United States

    hot-sale-high-purity-raw-powder-fox04-dri-nad-ghk-cu-mot

    2 PCS Dec 19, 2025
    United States

    foxo4 dri

    10 MT Dec 13, 2025
    United States

    Fox04

    10 MG Oct 30, 2024
    Germany

    FOXO4-DRI

    10 MG Sep 17, 2026
    Norway

    FOXO4-DRI

    200 MG Sep 3, 2026
    United Kingdom

    High purity foxo4

    1 G May 31, 2026
    United Kingdom

    Foxo4-Dri

    10 MG May 5, 2026
    United States

    Fox04-dri

    100 MG Apr 28, 2026
    Cyprus

    Foxo4 dri

    10 MT Apr 4, 2026
    Cyprus

    FOXO4-DRI

    1 KG Feb 2, 2026
    United States

    FOX04-DRI

    10 PCS Jan 12, 2026
    United States

    FOX04

    10 PCS Jan 12, 2026
    United States

    Foxo4 Dri

    40 MG Sep 15, 2025
    United States

    Fox04 dri

    10 MT Jun 21, 2026
    United States

    FOX04-DRI powder

    10 MT May 29, 2026
    United States

    fox04

    1 G Apr 29, 2026
    United States

    FOXO4-DRI

    1 KG Mar 23, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.